USPH Stock - U.S. Physical Therapy, Inc.
Unlock GoAI Insights for USPH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $671.35M | $604.80M | $553.14M | $495.02M | $422.97M |
| Gross Profit | $123.92M | $121.51M | $112.02M | $117.18M | $94.45M |
| Gross Margin | 18.5% | 20.1% | 20.3% | 23.7% | 22.3% |
| Operating Income | $63.21M | $52.06M | $56.80M | $70.65M | $52.41M |
| Net Income | $26.46M | $14.67M | $28.27M | $27.82M | $30.56M |
| Net Margin | 3.9% | 2.4% | 5.1% | 5.6% | 7.2% |
| EPS | $1.84 | $1.28 | $3.34 | $4.49 | $4.09 |
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 18th 2025 | JP Morgan | Resumed | Overweight | $110 |
| December 16th 2024 | JMP Securities | Initiation | Mkt Outperform | $113 |
| December 16th 2024 | BofA Securities | Upgrade | Buy | $115← $100 |
| October 7th 2024 | BofA Securities | Downgrade | Neutral | $90← $114 |
| September 22nd 2023 | JP Morgan | Initiation | Overweight | $108 |
| June 30th 2023 | BofA Securities | Initiation | Buy | $138 |
Earnings History & Surprises
USPHEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | $0.67 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.67 | $0.66 | -1.5% | ✗ MISS |
Q3 2025 | Aug 6, 2025 | $0.71 | $0.81 | +14.1% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $0.46 | $0.48 | +4.3% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $0.69 | $0.65 | -5.8% | ✗ MISS |
Q4 2024 | Nov 5, 2024 | $0.68 | $0.69 | +1.5% | ✓ BEAT |
Q3 2024 | Aug 13, 2024 | $0.81 | $0.73 | -9.9% | ✗ MISS |
Q2 2024 | May 7, 2024 | $0.56 | $0.51 | -8.9% | ✗ MISS |
Q1 2024 | Feb 28, 2024 | $0.57 | $0.59 | +3.5% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $0.62 | $0.62 | 0.0% | = MET |
Q3 2023 | Aug 8, 2023 | $0.75 | $0.76 | +1.3% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.52 | $0.59 | +13.5% | ✓ BEAT |
Q1 2023 | Feb 22, 2023 | $0.58 | $0.58 | 0.0% | = MET |
Q4 2022 | Nov 2, 2022 | $0.56 | $0.58 | +3.6% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $0.95 | $0.90 | -5.3% | ✗ MISS |
Q2 2022 | May 5, 2022 | $0.63 | $0.65 | +3.2% | ✓ BEAT |
Q1 2022 | Feb 24, 2022 | $0.69 | $0.72 | +4.3% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.78 | $0.85 | +9.0% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $0.73 | $0.96 | +31.5% | ✓ BEAT |
Frequently Asked Questions about USPH
What is USPH's current stock price?
What is the analyst price target for USPH?
What sector is U.S. Physical Therapy, Inc. in?
What is USPH's market cap?
Does USPH pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to USPH for comparison